Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Gilead scores PrEP approval for Descovy — kicking off marketing push before Truvada generics swarm
Endpoints
Thu, 10/3/19 - 10:21 pm
Gilead Sciences
Descovy
HIV
PrEP
FDA
Truvada
generics
GlaxoSmithKline halts generic Zantac supply as global threat gains steam
Fierce Pharma
Thu, 09/26/19 - 10:50 am
Novartis
GSK
generics
OTC
Zantac
product recalls
Pharma companies admit to sharing 'sensitive' info to keep prices high
Fierce Pharma
Tue, 09/24/19 - 10:06 am
UK
generics
price fixing
collusion
King Pharmaceuticals
Alissa Healthcare
US judge paves way for branded and generic opioid makers to face landmark October trial
Endpoints
Wed, 09/4/19 - 10:15 am
opioids
opioid crisis
generics
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Novartis
Sandoz
generics
biosimilars
Tysabri
Polpharma
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Fierce Pharma
Tue, 09/3/19 - 10:24 am
Mylan
Lantus
generics
Biocon
drug manufacturing
diabetes
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
BioSpace
Mon, 09/2/19 - 12:25 pm
Eli Lilly
Mylan
Alimta
FDA
generics
lung cancer
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Pharmaforum
Fri, 08/30/19 - 10:48 am
Mylan
Eli Lilly
generics
Alimta
non-squamous non-small cell lung cancer
mesothelioma
Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.
BioSpace
Thu, 08/29/19 - 08:16 pm
diabetes
insulin
Humalog
generics
Eli Lilly
Lispro
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Thu, 08/22/19 - 05:01 pm
Novo Nordisk
Mylan
generics
Victoza
diabetes
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Fierce Pharma
Mon, 08/19/19 - 11:46 pm
Pfizer
patents
Lyrica
generics
Generic Drug Approvals Hit Another Record High as Competition, Quality Questions Linger
RAPS.org
Fri, 08/16/19 - 11:52 pm
generics
FDA
Sanofi defends top oncology drug with Jevtana patent win
Fierce Pharma
Thu, 08/15/19 - 12:21 pm
Sanofi
patents
generics
Jevtana
oncology
3 generic drugmakers accused of 'stonewalling' congressional probe
Beckers Hospital Review
Thu, 08/15/19 - 10:41 am
generics
Mylan
Teva Pharmaceutical
Heritage Pharmaceuticals
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Fierce Pharma
Thu, 08/15/19 - 10:39 am
FDA
Dr Reddy's
Copaxone
Teva Pharmaceutical
generics
Merck
Nuvaring
What Enbrel needs to do after its patent win
EP Vantage
Mon, 08/12/19 - 11:48 am
Amgen
Enbrel
patents
generics
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Amgen
Enbrel
patents
Sandoz
generics
GAO Pushes FDA to Improve First Cycle Generic Approval Rate
RAPS.org
Fri, 08/9/19 - 07:41 pm
GAO
drug approvals
FDA
generics
Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff
Endpoints
Tue, 08/6/19 - 01:05 pm
Mallinckrodt
opioids
generics
Sonorant Therapeutics
SpecGx
Drugmakers master rolling out their own generics to stifle competition
Fierce Pharma
Mon, 08/5/19 - 10:39 am
generics
PDL Biopharma
Tekturna
Hatch Waxman Act
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »